Gotu Kola: Can This Ancient Herb Ease Seizures?
"Unveiling the Potential of Centella Asiatica in Managing Epilepsy"
Epilepsy affects millions worldwide, presenting as frequent seizures due to irregular brain activity. These seizures vary, depending on where the disturbance begins and how far it spreads. Ancient Indian literature, dating back to 500-1000 BC, recognized this condition, calling it Apasmara.
Approximately 2.4 million people are diagnosed with epilepsy each year globally. Though many lead normal lives with proper treatment, finding effective solutions remains crucial. In a significant number of cases, the cause is unknown, often emerging in childhood and affecting nearly 0.8% of children under seven.
While several drugs are available, the goal is to minimize seizures with tolerable side effects. Unfortunately, existing medications can be ineffective for some and often come with significant adverse reactions. This challenge has prompted exploration into natural remedies, including those from plants, to find better tolerated and more effective treatments for epilepsy.
Epilepsy Data and Gotu Kola Research
The CDC provides epilepsy facts and statistics, including U.S. data from 2021 and 2022 on active epilepsy prevalence by age, educational level, race and ethnicity, sex, employment status, and insurance coverage. The CDC also reports data on self-rated health and disability status among adults with active epilepsy. Research has examined Gotu kola, scientifically known as Centella asiatica, in pentylenetetrazol-induced seizure models, including a 2010 evaluation focused on cholinergic neurotransmission.
Promising Preclinical Evidence, Limited Clinical Support
A 2023 study reported that a standardized Centella asiatica extract produced anticonvulsant activity in a lithium/pilocarpine model without hepatotoxicity, nephrotoxicity, or changes in hematological parameters at the reported effective dose. The same research area notes that Centella asiatica has been used for epilepsy in traditional oriental medicine. However, clinical studies supporting chronic use in human epilepsy patients are lacking.
Centella Asiatica: A Natural Anticonvulsant?
Centella asiatica, or Gotu Kola, is a perennial creeper traditionally used in Ayurvedic medicine for various conditions, including epilepsy. Found across India, this herb has garnered attention for its potential anticonvulsant properties. A recent study published in the International Journal of Pharmacy and Pharmaceutical Sciences evaluated the effectiveness of an aqueous extract of Centella asiatica on seizures in albino mice.
- MES Model: Mice were subjected to electric shock to induce seizures, and the researchers observed the effects of Centella asiatica on seizure duration and severity.
- PTZ Model: Pentylenetetrazole was used to induce seizures chemically, allowing researchers to evaluate how Centella asiatica affected seizure latency and hind limb extension.
- Statistical Analysis: One-way ANOVA followed by the Tukey-Kramer test was used to determine the significance of the results, with a p-value less than 0.05 considered significant.
Recent Animal-Model Findings
Reviews of epilepsy research describe continued investigation of plant extracts and phytoconstituents as possible treatment candidates. In a 2023 rat study, Centella asiatica at 400 mg/kg increased the latency to the first generalized seizure and to status epilepticus onset, while also significantly reducing the time to the first generalized seizure compared with the vehicle group. Separate research on Phyllanthus urinaria in Swiss albino rats reported delayed tonic and clonic seizures, improved protection against mortality, and significant anticonvulsant activity.
Extract Composition and Alternative Comparisons
A study of 50% ethanolic Pegagan, or Centella asiatica, extract identified the triterpene glycoside asiaticoside and reported no immunomodulatory effect in the tested mouse model. Standardization research examines Centella asiatica extract constituents including asiaticoside, asiatic acid, and madecasic acid, using a specified ethyl acetate, methanol, and water mobile-phase mixture for asiaticoside analysis. Comparison resources present Gotu kola alternatives through evidence scores or head-to-head information on uses, ratings, costs, side effects, and interactions, but the supplied material does not establish that any alternative is superior for seizure control.
The Future of Centella Asiatica in Epilepsy Treatment
The study highlights the potential of Centella asiatica as a natural remedy for epilepsy, particularly in managing tonic-clonic and absence seizures. While these findings are promising, further research is essential to understand the herb’s exact mechanisms, identify its active compounds, and confirm its safety for long-term use. These steps will pave the way for integrating Centella asiatica into modern epilepsy treatment strategies, potentially offering a more natural and better-tolerated option for those affected by this condition.
Market Growth and Product Development
Recent market reports frame Gotu kola extract as part of a developing health-products sector. The Business Research Company report covers global market size, regional shares, competitors, market segments, trends, and opportunities for 2026-2030. Other reports emphasize growth trends, demand for herbal supplements, natural-health ingredient applications, technological advancements, changing consumer preferences, and regulatory developments through 2035 or 2034.
Traditional Use and Experimental Models
Gotu kola is scientifically named Centella asiatica and belongs to the Apiaceae, or Umbelliferae, family. The plant is described as an herbaceous annual native to Asia. Research on its possible antiepileptic effects has used pentylenetetrazol-induced epilepsy models and examined cholinergic alterations, highlighting the gap between traditional use and evidence generated in experimental systems.
What the Preclinical Findings Mean
A study of Centella asiatica examined n-hexane, ethyl acetate, and n-butanol extracts in pentylenetetrazol-induced epilepsy. It reported that these extracts considerably reduced the cholinergic alterations associated with the experimental model. The authors stated that the extracts or their bioactive components could be used to treat epilepsy or control seizure generation, but the supplied source describes an experimental study rather than established human treatment outcomes.